Bincy Abraham

5.6k total citations · 2 hit papers
129 papers, 3.8k citations indexed

About

Bincy Abraham is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Bincy Abraham has authored 129 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Genetics, 63 papers in Epidemiology and 49 papers in Surgery. Recurrent topics in Bincy Abraham's work include Inflammatory Bowel Disease (86 papers), Microscopic Colitis (56 papers) and Eosinophilic Esophagitis (28 papers). Bincy Abraham is often cited by papers focused on Inflammatory Bowel Disease (86 papers), Microscopic Colitis (56 papers) and Eosinophilic Esophagitis (28 papers). Bincy Abraham collaborates with scholars based in United States, Belgium and Canada. Bincy Abraham's co-authors include Hashem B. El‐Serag, Eamonn M.M. Quigley, Jason K. Hou, Kerri Glassner, Joseph H. Sellin, Seema Mehta, Sunanda V. Kane, Hoda M. Malaty, John K. DiBaise and Ernest P. Bouras and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Bincy Abraham

111 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature

2011 736 citations Bincy Abraham et al. profile →
The microbiome and inflammatory bowel disease

2020 603 citations Kerri Glassner, Bincy Abraham et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bincy Abraham United States	27	1.6k	1.1k	1.1k	1.0k	766	129	3.8k
Makoto Naganuma Japan	37	1.9k 1.2×	1.2k 1.1×	1.1k 1.1×	1.4k 1.4×	712 0.9×	233	4.8k
Luc Biedermann Switzerland	33	1.4k 0.9×	1.3k 1.2×	941 0.9×	1.1k 1.0×	424 0.6×	197	3.8k
Giovanni Latella Italy	41	1.8k 1.2×	1.3k 1.2×	969 0.9×	1.3k 1.3×	598 0.8×	134	4.3k
Gabriele Riegler Italy	29	1.6k 1.0×	1.3k 1.1×	621 0.6×	1.4k 1.3×	768 1.0×	84	3.7k
Hirotsugu Imaeda Japan	26	1.2k 0.8×	1.1k 1.0×	1.4k 1.3×	656 0.6×	473 0.6×	73	3.5k
Vera Ballet Belgium	26	2.2k 1.4×	835 0.7×	1.4k 1.3×	1.6k 1.6×	437 0.6×	76	4.1k
Jana G. Hashash United States	31	1.6k 1.1×	1.1k 1.0×	515 0.5×	1.4k 1.3×	549 0.7×	249	3.7k
Tomoyuki Tsujikawa Japan	35	1.7k 1.1×	1.4k 1.2×	1.3k 1.2×	966 0.9×	584 0.8×	145	5.3k
Heitor Siffert Pereira de Souza Brazil	33	1.3k 0.8×	842 0.8×	1.5k 1.4×	810 0.8×	320 0.4×	99	4.3k
Graham Radford‐Smith Australia	34	2.0k 1.3×	1.0k 0.9×	1.0k 0.9×	1.4k 1.3×	297 0.4×	99	4.0k

Countries citing papers authored by Bincy Abraham

Since Specialization

Citations

This map shows the geographic impact of Bincy Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bincy Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bincy Abraham more than expected).

Fields of papers citing papers by Bincy Abraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bincy Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bincy Abraham. The network helps show where Bincy Abraham may publish in the future.

Co-authorship network of co-authors of Bincy Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Bincy Abraham. A scholar is included among the top collaborators of Bincy Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bincy Abraham. Bincy Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Irani, Mohamad, et al.. (2025). A Guide to De-escalation of Combination Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study. Crohn s & Colitis 360. 7(2). otaf026–otaf026.

Abraham, Bincy, Jianmin Wu, Séverine Vermeire, et al.. (2025). Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT Trials. Crohn s & Colitis 360. 7(2). otaf002–otaf002.

Glassner, Kerri, et al.. (2024). Therapeutic Potential of Etrasimod in the Management of Moderately-to-Severely Active Ulcerative Colitis: Evidence to Date. Clinical and Experimental Gastroenterology. Volume 17. 337–345. 5 indexed citations

Long, Millie D., Sunanda V. Kane, Dawn B. Beaulieu, et al.. (2024). Mo1871 USE OF BIOSIMILARS TO INFLIXIMAB DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE. Gastroenterology. 166(5). S–1153. 4 indexed citations

Glassner, Kerri, et al.. (2024). Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab. Journal of Digestive Diseases. 25(4). 214–221. 1 indexed citations

Glassner, Kerri, et al.. (2024). Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab. Journal of Digestive Diseases. 25(2). 91–99. 2 indexed citations

Dubinsky, Marla C., Raja Atreya, Bincy Abraham, et al.. (2024). 763 RISANKIZUMAB VERSUS USTEKINUMAB FOR THE ACHIEVEMENT OF CLINICAL REMISSION AND REDUCTION IN INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: RESULTS FROM THE PHASE 3B SEQUENCE TRIAL. Gastroenterology. 166(5). S–182. 2 indexed citations

Chavannes, Mallory, Michael T. Dolinger, Shirley Cohen‐Mekelburg, & Bincy Abraham. (2024). AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary. Clinical Gastroenterology and Hepatology. 22(9). 1790–1795.e1. 27 indexed citations

Abraham, Bincy. (2023). Real-world impact of infliximab precision-guided dosing on management of patients with IBD. The American Journal of Managed Care. 29(Suppl 12). S227–S235. 3 indexed citations

10.

Abraham, Bincy, et al.. (2023). Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started. Crohn s & Colitis 360. 5(3). otad043–otad043. 2 indexed citations

11.

Quigley, Eamonn M.M., et al.. (2023). The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis. Digestive Diseases. 41(4). 656–665. 12 indexed citations

12.

Abraham, Bincy, et al.. (2023). Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease. Crohn s & Colitis 360. 5(3). otad027–otad027. 11 indexed citations

13.

Alayo, Quazim A., Osama Altayar, Kerri Glassner, et al.. (2022). Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease. Crohn s & Colitis 360. 4(1). otac002–otac002. 57 indexed citations

14.

Abraham, Bincy, Elyssa Ott, Lindsay Miller, et al.. (2022). Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis. Crohn s & Colitis 360. 4(3). otac025–otac025. 11 indexed citations

15.

Nasir, Khurram, Isaac Acquah, Amit K. Dey, et al.. (2022). Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults—A population-level analysis in the national health interview survey. SHILAP Revista de lepidopterología. 9. 100316–100316. 17 indexed citations

16.

Long, Millie D., Corey A. Siegel, Bincy Abraham, Michael Chiorean, & Uma Mahadevan. (2021). Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 20(3). 706–708.e1. 6 indexed citations

17.

Osterman, Mark T., Kelli L. VanDussen, Ilyssa O. Gordon, et al.. (2020). Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease. Inflammatory Bowel Diseases. 27(5). 677–685. 9 indexed citations

18.

Glassner, Kerri, Bincy Abraham, & Eamonn M.M. Quigley. (2020). The microbiome and inflammatory bowel disease. Journal of Allergy and Clinical Immunology. 145(1). 16–27. 603 indexed citations breakdown →

19.

Glassner, Kerri & Bincy Abraham. (2019). The use of vedolizumab in pregnancy and breastfeeding in women with inflammatory bowel disease. 43(9). 13–18. 1 indexed citations

20.

Abraham, Bincy & Eamonn M.M. Quigley. (2017). Probiotics in Inflammatory Bowel Disease. Gastroenterology Clinics of North America. 46(4). 769–782. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact